GlassScriptPhysician profile
Christian Cobbold
NPI 1487775771
$4,698.18
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,046 · 2020: $477 · 2021: $1,009 · 2022: $485 · 2023: $446 · 2024: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,488.38 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $576.65 | 2019-2024 | Wegovy |
| Amgen INC. | $429.23 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $259.75 | 2019-2022 | |
| Lilly USA, LLC | $112.76 | 2019-2021 | |
| Pfizer INC. | $99.53 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $89.64 | 2021 | |
| Amarin Pharma, INC. | $65.93 | 2020 | |
| Esperion Therapeutics, INC. | $65.76 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $63.71 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.91 | 2021-2022 | |
| Astellas Pharma US INC | $56.35 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.00 | 2019 | |
| Nestle Healthcare Nutrition INC. | $47.18 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.26 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $42.51 | 2020-2021 | |
| Abbvie INC. | $38.87 | 2019-2021 | |
| Sanofi Pasteur INC. | $31.77 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.16 | 2022 | |
| Allergan, INC. | $14.83 | 2020 | |
| Glaxosmithkline, LLC. | $13.73 | 2021 | |
| Genentech USA, INC. | $13.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Cobbold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.